2010
DOI: 10.1016/j.prp.2010.08.001
|View full text |Cite
|
Sign up to set email alerts
|

Expression of Neuropilin-2 in salivary adenoid cystic carcinoma: Its implication in tumor progression and angiogenesis

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

2
21
0

Year Published

2012
2012
2017
2017

Publication Types

Select...
8
1

Relationship

0
9

Authors

Journals

citations
Cited by 23 publications
(23 citation statements)
references
References 25 publications
2
21
0
Order By: Relevance
“…Using the cell line ACC-3, inhibition of Nrp2 function with antibody resulted in decreased cell migration, invasion and angiogenesis promotion without influence on the cell proliferation. It was suggested that Nrp2 expression may be correlated with tumor progression and angiogenesis in ACC [71].…”
Section: Other Factorsmentioning
confidence: 99%
“…Using the cell line ACC-3, inhibition of Nrp2 function with antibody resulted in decreased cell migration, invasion and angiogenesis promotion without influence on the cell proliferation. It was suggested that Nrp2 expression may be correlated with tumor progression and angiogenesis in ACC [71].…”
Section: Other Factorsmentioning
confidence: 99%
“…3940,43 Patients with distant metastasis have a 5-year survival rate as low as 20%. 38 Overall low survival is primarily due to the persistence of tumor growth, late recurrence after initial treatment, perineural invasion, hematogenous spread and invasion to distant and neighboring tissues. 4447 …”
Section: Introductionmentioning
confidence: 99%
“…As an additional example, Nrp2 expression has been reported in gastrointestinal cancer cells but not in the normal surrounding mucosa and Nrp2 knockdown leads to decreased migration and invasion in vitro (116). Nrp2 expression is also observed in salivary adenoid cystic carcinoma and is highly correlated with microvessel density, tumor size, invasion and metastasis (117). A number of factors make Nrp2 a particularly promising target for therapeutic intervention (Figure 4).…”
Section: Nrp In Tumor Metastasismentioning
confidence: 99%
“…Specifically, Nrp2 expression is seen in a significant number of tumors where it contributes to tumor metastasis and progression. Indeed, use of a Nrp2 monoclonal antibody has been reported to decrease tumor metastasis (73, 117). Additionally, Nrp2 knockout does not result in embryonic lethality, indicating that therapeutic inhibition of Nrp2 function may be well tolerated in vivo .…”
Section: Nrp In Tumor Metastasismentioning
confidence: 99%